HLVX HilleVax Inc
Price (delayed)
$1.88
Market cap
$93.6M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.39
Enterprise value
$34.6M
Highlights
HLVX's EPS has dropped by 76% year-on-year and by 2.7% since the previous quarter
HilleVax's net income has shrunk by 68% YoY and by 9% QoQ
Key stats
What are the main financial stats of HLVX
Market
Valuations
Earnings
Shares outstanding
49.78M
Market cap
$93.6M
Enterprise value
$34.6M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$153.36M
EBITDA
-$150.49M
Free cash flow
-$114.32M
Per share
Balance sheet
Liquidity
EPS
-$3.39
Free cash flow per share
-$2.32
Book value per share
$4.12
Revenue per share
$0
TBVPS
$5.63
Total assets
$276.93M
Total liabilities
$72M
Debt
$51.08M
Equity
$204.93M
Working capital
$203.36M
Debt to equity
0.25
Current ratio
5.14
Quick ratio
5.02
Net debt/EBITDA
0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-48%
Return on equity
-62%
Return on invested capital
-87.3%
Return on capital employed
-67.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HLVX stock price
How has the HilleVax stock price performed over time
Intraday
3.87%
1 week
9.94%
1 month
5.03%
1 year
-87.19%
YTD
-88.29%
QTD
-87%
Financial performance
How have HilleVax's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$166.96M
Net income
-$156.27M
Gross margin
N/A
Net margin
N/A
HilleVax's net income has shrunk by 68% YoY and by 9% QoQ
HilleVax's operating income has shrunk by 67% YoY and by 8% QoQ
Growth
What is HilleVax's growth rate over time
Valuation
What is HilleVax stock price valuation
P/E
N/A
P/B
0.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
HLVX's EPS has dropped by 76% year-on-year and by 2.7% since the previous quarter
HLVX's price to book (P/B) is 85% less than its last 4 quarters average of 2.9
The equity has declined by 14% since the previous quarter and by 6% year-on-year
Efficiency
How efficient is HilleVax business performance
HilleVax's ROE has plunged by 70% YoY and by 10% from the previous quarter
The return on assets has dropped by 58% year-on-year and by 10% since the previous quarter
The ROIC has grown by 24% YoY but it has contracted by 7% from the previous quarter
Dividends
What is HLVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HLVX.
Financial health
How did HilleVax financials performed over time
HLVX's quick ratio has dropped by 63% year-on-year and by 53% since the previous quarter
The company's current ratio has shrunk by 63% YoY and by 53% QoQ
HLVX's debt is 75% smaller than its equity
The debt to equity has grown by 19% since the previous quarter and by 14% year-on-year
The equity has declined by 14% since the previous quarter and by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.